Briviact
Showing 1 - 15 of 15
Alzheimer, Mild Cognitive Impairment Trial in Los Angeles (Brivaracetam)
Not yet recruiting
- Alzheimer Disease
- Mild Cognitive Impairment
-
Los Angeles, CaliforniaMary S. Easton Center for Alzheimer's Research and Care
Jun 1, 2023
Electroencephalographic Neonatal Seizures Trial in Worldwide (Brivaracetam (BRV) intravenous (iv), Brivaracetam (BRV) oral)
Terminated
- Electroencephalographic Neonatal Seizures
- Brivaracetam (BRV) intravenous (iv)
- Brivaracetam (BRV) oral
-
Leuven, Belgium
- +5 more
Mar 10, 2022
Partial Seizure Trial in Tianjin (Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB), Brivaracetam sustained-release tablets
Active, not recruiting
- Partial Seizure
- Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB)
- +2 more
-
Tianjin, Tianjin, ChinaTianjin Municipal People's Hospital
Jan 31, 2023
Drug Concentrations in Breast Milk and Prediction of Blood
Recruiting
- Breast Feeding
- either of Atenolol, Bupropion, Brivaracetam, Escitalopram, Fluconazole, Lacosamide, Lamotrigine, Levetiracetam, Methotrexate or Ezetimibe
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Sep 15, 2022
ive Briviact is as add-on Treatment for Epilepsy With Partial
Completed
- Epilepsy With POS With or Without Secondary Generalization
-
Aarhus, Denmark
- +43 more
Jul 12, 2021
Partial Seizures With or Without Secondary Generalization, Epilepsy Trial in Japan (Brivaracetam)
Completed
- Partial Seizures With or Without Secondary Generalization
- Epilepsy
-
Asaka, Japan
- +8 more
Apr 12, 2021
Childhood Absence Epilepsy, Juvenile Absence Epilepsy Trial in Worldwide (Brivaracetam Film-coated tablet, Brivaracetam oral
Enrolling by invitation
- Childhood Absence Epilepsy
- Juvenile Absence Epilepsy
- Brivaracetam Film-coated tablet
- Brivaracetam oral solution
-
Birmingham, Alabama
- +21 more
Jan 5, 2023
